Evidence map›Paper›PMID 24503100›Full record

ArticleVirology2014

Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.

Namal P M Liyanage, Shari N Gordon, Melvin N Doster, Poonam Pegu, Monica Vaccari, Nebiyu Shukur, Luca Schifanella, Cynthia A Pise-Masison, Danuta Lipinska, Kamil Grubczak and 2 more

Open access · greenAbstract read
In one paragraph

Article in Virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Differential Effect of Mucosal NKp44Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  11. Evaluation of an antibody to αScience (New York, N.Y.) · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Innate Lymphoid Cells in HIV/SIV Infections.Frontiers in immunology · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 3 countries.

Namal P M LiyanageAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA.
Shari N GordonAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA.
Melvin N DosterAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA.
Poonam PeguAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA.
Monica VaccariAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA.
Nebiyu ShukurAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA.
Luca SchifanellaAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA.
Cynthia A Pise-MasisonAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA.
Danuta LipinskaDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-269 Bialystok, Poland.
Kamil GrubczakDepartment of Immunology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Marcin MoniuszkoDepartment of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-269 Bialystok, Poland; Department of Allergology and Internal Medicine, Medical University of Bialystok, 15-269 Bialystok, Poland.
Genoveffa FranchiniAnimal Models & Retroviral Vaccines Section, NCI, NIH, Bethesda, MD 20892, USA. Electronic address: franchig@mail.nih.gov.
National Institutes of Health · USMedical University of Białystok · PL

Funding

Preventive Vaccines for HIVZIABC011126 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI FRANCHINI, GENOVEFFA · 2009 to 2025
$55.3M
TRAINING IN IMMUNOLOGY AND MOLECULAR PATHOGENESIST32AI007610 · NIAID · EMORY UNIVERSITY · PI EVAVOLD, BRIAN D · 2000 to 2014
$4.4M
Intramural NIH HHS Z99 CA999999NIAID NIH HHS T32 AI007610
6 · The paper itself

Abstract

We characterized three subsets of NK cells in blood, and two subsets in mucosal tissues. SIVmac251 infection increased total and CD16(+) NK cells in the blood. In the rectum, we observed a significant increase in total and NKG2A(+) NK cells during SIV infection. In contrast, the NKp44(+) subset significantly depleted in acute infection and continued to decline in frequency during chronic phase. During SIV infection, blood CD16 and mucosal NKG2A(+) subsets had increased cytotoxic potential. Intriguingly, the NKp44(+) NK cell subtype that likely mediates mucosal homeostasis via the production of cytokines, acquired cytotoxicity. Antiretroviral therapy significantly increased the frequency of mucosal NKG2A(+) NK cells and peripheral CD16(+) NK cells. However, it failed to restore the normal frequency of NKp44(+) NK cells in the rectum. Thus, SIVmac251 infection causes changes in the distribution and function of NK cells and antiretroviral therapy during chronic infection only partially restores NK homeostasis and function.

Indexed as

AnimalsAnti-HIV AgentsDisease Models, AnimalHIV-1HIV InfectionsHumansKiller Cells, NaturalLeukocyte CountMacacaMacaca mulattaMucous MembraneRectumSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnti-HIV AgentsARTChemokine receptorHAARTHIVInnate immunityInnate lymphoid cellsMacaquesMucosalNK cellSIV

Identifiers

PMID24503100
PMCPMC5008240
OpenAlexW2041918949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.